Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Avi Kapoor
MIRA Pharmaceuticals shares surged 44.8% in pre-market trading after announcing a successful rat study with Ketamin-2. Other notable pre-market movers include MEDIROM Healthcare, Prestige Wealth, and Tevogen Bio, among others.
August 26, 2024 | 9:58 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MIRA Pharmaceuticals shares rose 44.8% in pre-market trading following a successful rat study showing 100% reversal of neuropathic pain with oral Ketamin-2.
The significant pre-market price increase is directly linked to the positive results from the rat study, indicating potential future success in human trials, which is a strong positive signal for investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
MEDIROM Healthcare Technologies shares gained 135.5% in pre-market trading after announcing a partnership with NFES Technologies.
The substantial pre-market gain is due to the strategic partnership announcement, which could enhance business prospects and investor confidence.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 80
POSITIVE IMPACT
Prestige Wealth shares rose 57% in pre-market trading after announcing an acquisition agreement to purchase all shares of SPW Global.
The acquisition agreement is a significant development, likely boosting investor sentiment and leading to the sharp pre-market price increase.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 75
POSITIVE IMPACT
Tevogen Bio shares gained 32.8% in pre-market trading after securing a $6 million Series C investment.
The Series C investment provides financial backing for future growth, positively impacting investor sentiment and share price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 70